Controversies in contraception

Area of Science:

• Reproductive Health
• Adolescent Medicine
• Pharmacology

Background:

• Emerging research continually updates understanding of hormonal contraceptives.
• Contraceptive use in adolescents presents unique considerations regarding efficacy and side effects.
• Providers require current information to effectively manage adolescent contraceptive care.

Purpose of the Study:

• To review recent research on hormonal contraceptives and adolescent health.
• To highlight key areas of emerging evidence and controversy in contraceptive care.
• To inform healthcare providers about critical updates for adolescent patient counseling.

Main Methods:

• Literature review of recent studies on hormonal contraceptives.
• Analysis of research concerning bone health, migraines, thrombosis, hypertension, weight gain, obesity, and emergency contraception.
• Synthesis of findings to identify clinical implications for adolescent care.

Main Results:

• Depot medroxyprogesterone acetate and low-dose oral contraceptives may adversely affect adolescent bone health, though bone loss appears reversible.
• Estrogen-containing contraceptives are associated with migraine exacerbation, venous thromboembolism, and hypertension.
• Depot medroxyprogesterone acetate is linked to weight gain, particularly in overweight adolescents; obesity may reduce contraceptive efficacy.
• The mechanism of emergency contraception remains unclear, with evidence suggesting preovulatory effects.

Conclusions:

• Adolescent health providers must be informed about new research and controversies in contraceptive care.
• Effective counseling and patient care depend on awareness of evolving contraceptive evidence.
• Staying current with contraceptive research is essential for optimizing adolescent reproductive health outcomes.